Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06745128 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tirzepatide for Obesity and Meth Use Disorder

StatusCompleted
PhasePhase 2
Started2025-02-03
View on ClinicalTrials.gov ↗

Amendment history

2026-09-29
Trial completed
Final enrollment: 35 participants (planned 45)
Primary completion confirmed: February 2026 (last estimated March 2026)
2025-06-10
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v5
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2027-02-03→2026-03-31
Completion date2027-02-03→2026-03-31
Study sitesdetails revised at 1 of 1 site
2025-05-07
Study Status, Study Description, Study Design, Contacts/Locations, IPDSharing v4
Enrollment target30→45
Study descriptionrevised
This study will enroll up to 3045 individuals with moderate-to-severe methamphetamine use dis [...]
Study sitescontacts updated at 1 of 1 site
2025-04-24
Study Status, Contacts/Locations v3
Study sitescontacts updated at 1 of 1 site
2025-02-04
Study Status v2
Re-verified, no change to tracked fields
2025-01-29
Not Yet Recruiting→Recruiting Study Identification, Study Status, Outcome Measures, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
Secondary endpointsdetails revised at 1 of 5 entries
Study title+12 characters
Tirzepatide for Obesity and Meth Use Disorder
2024-12-17
Original filing
This is an open-label pilot study to evaluate the feasibility and preliminary efficacy of using tirzepatide when prescribed for its United States (US) Food and Drug Administration (FDA)-approved weight-related indication in individuals with comorbid methamphetamine use disorder.
Trial Details
NCT Number NCT06745128
Lead Sponsor University of Texas Southwestern Medical Center
Conditions Obesity, Methamphetamine Use Disorder
Enrollment 35 participants
Start Date 2025-02-03
Primary Completion 2026-02-12 (estimated)
Study Completion 2026-02-12 (estimated)
Updated on ClinicalTrials.gov 2026-09-28